Mahacef Drop contains Cefixime 25 mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of Gram-positive and Gram-negative bacteria. It is indicated for the treatment of various bacterial infections including otitis media, pharyngitis, tonsillitis, bronchitis, urinary tract infections, and uncomplicated gonorrhea. Cefixime acts by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Mahacef Drop is administered orally and is suitable for pediatric patients requiring precise dosing. The formulation ensures rapid absorption and adequate bioavailability, providing effective plasma concentrations to eradicate susceptible pathogens. It is important to complete the prescribed course to prevent the development of resistance. Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal pain. Hypersensitivity reactions, although rare, may occur and necessitate immediate discontinuation of therapy. Caution is advised in patients with a history of penicillin or cephalosporin allergy. Dose adjustment may be required in patients with renal impairment. Mahacef Drop should be stored in a cool, dry place away from direct sunlight. It is contraindicated in viral infections and should only be used under medical supervision to ensure appropriate use and monitoring for adverse effects.